World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
52386
World Ranking
5484
National Ranking
205

Overview

Harry J. de Koning is affiliated with Erasmus University Rotterdam in the Netherlands. Their research primarily focuses on the field of Medicine with an emphasis on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery, and Epidemiology.

The scientist's work covers a range of topics including:

  • Global Cancer Incidence and Screening
  • Lung Cancer Diagnosis and Treatment
  • Colorectal Cancer Screening and Detection
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Digital Radiography and Breast Imaging
  • Chronic Obstructive Pulmonary Disease (COPD) Research

Their publication record includes contributions to frequent venues such as:

  • European Journal of Cancer
  • Journal of Thoracic Oncology
  • International Journal of Cancer
  • JAMA Oncology
  • Radiology

Among recent papers authored by Harry J. de Koning are:

  • "Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial" (2020, New England Journal of Medicine)
  • "Personalized early detection and prevention of breast cancer: ENVISION consensus statement" (2020, Nature Reviews Clinical Oncology)
  • "Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography" (2021, JAMA)
  • "Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases" (2021, Hepatology)
  • "Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review" (2020, European Journal of Cancer)

Frequent co-authors collaborating with de Koning include:

  • Eveline A.M. Heijnsdijk
  • Matthijs Oudkerk
  • Carlijn M. van der Aalst
  • Kevin ten Haaf
  • Nicolien T. van Ravesteyn

Best Publications

  • Screening and Prostate-Cancer Mortality in a Randomized European Study

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

    Harry J. de Koning;Carlijn M. van der Aalst;Pim A. de Jong;Ernst T. Scholten

  • Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

    Mieke Kriege;Cecile T.M. Brekelmans;Carla Boetes;Peter E. Besnard

  • Prostate-Cancer Mortality at 11 Years of Follow-up

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

    Gerrit Draisma;Rob Boer;Suzie J. Otto;Ingrid W. van der Cruijsen

  • Management of lung nodules detected by volume CT scanning

    Rob J van Klaveren;Matthijs Oudkerk;Mathias Prokop;Ernst T Scholten

  • Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

    Gerrit Draisma;Ruth Etzioni;Alex Tsodikov;Angela Mariotto

  • Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

    Jeanne S. Mandelblatt;Kathleen A. Cronin;Stephanie Bailey;Donald A. Berry

  • Supplemental MRI Screening for Women with Extremely Dense Breast Tissue

    Marije F. Bakker;Stéphanie V. de Lange;Ruud M. Pijnappel;Ritse M. Mann

  • European position statement on lung cancer screening

    Matthijs Oudkerk;Anand Devaraj;Rozemarijn Vliegenthart;Thomas Henzler

  • Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force

    Harry J. de Koning;Rafael Meza;Sylvia K. Plevritis;Kevin ten Haaf

  • A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    Jonas Hugosson;Monique J. Roobol;Marianne Månsson;Teuvo L.J. Tammela

  • Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening

    Nanda Horeweg;Joost van Rosmalen;Marjolein A Heuvelmans;Carlijn M van der Aalst

  • Quality-of-life effects of prostate-specific antigen screening.

    Eveline A M Heijnsdijk;Elisabeth M Wever;Anssi Auvinen;Jonas Hugosson

  • Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review

    Donella Puliti;Stephen W Duffy;Guido Miccinesi;Harry de Koning

  • Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review.

    Suzie J. Otto;Jacques Fracheboud;Caspar W. N. Looman;Mireille J. M. Broeders

  • Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON)

    Carola A. van Iersel;Harry J. de Koning;Gerrit Draisma;Willem P. T. M. Mali

  • Prostate cancer detection at low prostate specific antigen.

    Fritz H. Schröder;Ingrid van der Cruijsen-Koeter;Harry J. de Koning;André N. Vis

  • Nodule management protocol of the NELSON randomised lung cancer screening trial

    Dong Ming Xu;Hester Gietema;Harry de Koning;René Vernhout

  • Lead Times and Overdetection Due to Prostate-Specific Antigen Screening

    Gerrit Draisma;Rob Boer;Suzie J. Otto;Ingrid W van der Cruijsen

Frequent Co-Authors

Matthijs Oudkerk
Matthijs Oudkerk University of Groningen
Willem P.Th.M. Mali
Willem P.Th.M. Mali Utrecht University
Harry J.M. Groen
Harry J.M. Groen University Medical Center Groningen
Rob J. de Boer
Rob J. de Boer Utrecht University
Marie-Louise Essink-Bot
Marie-Louise Essink-Bot University of Amsterdam
Jeanne S. Mandelblatt
Jeanne S. Mandelblatt Georgetown University
Mathias Prokop
Mathias Prokop Radboud University
Bram van Ginneken
Bram van Ginneken Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a future in medicine, several related online degrees and alternative career pathways offer flexibility and affordability. One popular option is starting with medical billing and coding classes online. These courses provide foundational knowledge in health data management and can lead to quick entry into the medical field.

Nursing remains a highly sought-after field with a variety of online programs. Prospective nurses can search for how much is online nursing school to compare costs and program options. For those aiming to advance their careers, there are also cheap np programs that prepare registered nurses for specialized, high-demand roles.

Ambitious professionals may also pursue online nursing doctoral programs, opening doors to research, teaching, or leadership positions. Researching these pathways allows students to tailor their education to fit both budget and career goals while supporting the growing needs of the healthcare industry.

Best Scientists Citing Harry J. de Koning

Trending Scientists

Recently Published Articles